|
|
|
| () | |
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Page 1 of 4
-
Pharmaceutical R&D Experiencing Fundamental Shift
on May 13, 2008 by Research Recap
-
Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?
on May 09, 2008 by Don Dion
-
Biotech Stocks' Various Lupus Therapies: Opportunity or Lost Cause?
on May 07, 2008 by Ketan Desai
-
Former Merck CEO Prods Industry on Drug Pricing
on May 02, 2008 by Mike Huckman
-
Drug Problems Spark Contrarian Reactions for Genentech, Merck
on Apr 29, 2008 by Andrew Wilkinson
-
Wall Street Breakfast: Must-Know News
on Apr 25, 2008 by SA Editor Eli Hoffmann
-
Genentech Earnings: Great Formatting, But Not So Great Sales
on Apr 13, 2008 by Mike Huckman
-
Fast Money Recap, 4/10/08: Retail Charges Ahead
on Apr 11, 2008 by SA Editor Miriam Metzinger
-
Wall Street Breakfast: Must-Know News
on Apr 11, 2008 by SA Editor Eli Hoffmann
-
Under The Radar News - Thursday
on Apr 10, 2008 by SA Editor Eli Hoffmann
-
Ten Companies Involved in Treating Asthma
on Mar 31, 2008 by Stockerblog
-
Genentech's Avastin: An Undeserving Target for Politicians and the Media
on Mar 26, 2008 by Michael Shulman
-
Gilead Sciences 'Pushes Out' Amgen As Number 2 Biotech
on Mar 24, 2008 by Mike Huckman
-
Genentech: Mixed Reactions to Investor Meeting
on Mar 17, 2008 by Mike Huckman
-
The Future of ImmunoGen - Care of Genentech
on Mar 17, 2008 by David Rau
-
Genentech Meeting: Conservative Guidance Under Casual Dress
on Mar 16, 2008 by Mike Huckman
-
Genentech in 2007: Stock Ends Down, Exec. Comp. Goes Up
on Mar 13, 2008 by Mike Huckman
-
Under The Radar News - Thursday
on Mar 13, 2008 by SA Editor Eli Hoffmann
-
Amgen and Genentech: Biotech Double Play
on Mar 10, 2008 by Mike Huckman
-
How Genentech Got Its Groove Back
on Feb 26, 2008 by Mike Huckman
-
Monday's Options Report: ABK, XLF, WB, GTXI, QCOM, NTAP, DNA, TTWO
on Feb 25, 2008 by Andrew Wilkinson
-
Wall Street Breakfast: Must-Know News
on Feb 25, 2008 by SA Editor Eli Hoffmann
-
Earnings Rundown: Are Stocks Gaining Traction?
on Feb 14, 2008 by Wall Street Strategies
-
Wednesday's Options Report: HUM, AET, UNH, YHOO, AA, FSLR, XLB, DNA
on Feb 13, 2008 by Andrew Wilkinson
-
Wall Street Breakfast: Must-Know News
on Feb 13, 2008 by SA Editor Judith Levy
-
Gold's Just Getting Started - Barron's Interview
on Feb 04, 2008 by SA Editor Eli Hoffmann
-
PowerShares Dynamic Pharmaceuticals ETF Faces Host of Challenges
on Jan 25, 2008 by Don Dion
-
Wall Street Breakfast: Must-Know News
on Jan 22, 2008 by SA Editor Judith Levy
-
Investors May Prefer to Stay Away from DNA
on Jan 15, 2008 by Brett Scott
-
Pharma, Biotech Present Great Investment Opportunities in 2008
on Jan 09, 2008 by A. Reza Saadat
-
My Take on Fortune's Best Stocks for 2008
on Jan 08, 2008 by Jake Berzon
-
Biogenerics: Not Yet a Reality in the U.S.
on Dec 24, 2007 by Trader Thoughts
-
The Bells Toll Less for the Biotechs
on Dec 19, 2007 by Derek Lowe
-
Genentech Will Recover from FDA's Rejection of Avastin
on Dec 06, 2007 by Chris Krasowski
-
Thursday's Options Report: FDO, Target, AIG, HOKU, DNA, TKC, FDG
on Dec 06, 2007 by Andrew Wilkinson
-
FDA Panel Rejects Avastin for Breast Cancer
on Dec 06, 2007 by SA Editor Judith Levy
-
Genentech Stock Slide: FDA Meeting Should Have Been Webcast
on Dec 06, 2007 by Paul Kedrosky
-
Monday's Options Report: GE, XLF, DIA, UNTD, Activision, E*Trade, DNA, PAY, SHW
on Dec 03, 2007 by Andrew Wilkinson
-
Genentech's Avastin Slows Down Brain Cancer - Study
on Nov 19, 2007 by SA Editor Judith Levy
-
Andy Grove: Rich, Famous, Smart and Wrong About Drugmakers
on Nov 06, 2007 by Derek Lowe
-
Genentech Beats, But Street Wanted More
on Oct 15, 2007 by SA Editor Roy Mehta
Get Free Stock Alerts by Email!
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »